Acute Hemolysis Due to Metformin in a Young Adult Treated for T-Cell Acute Lymphoblastic Leukemia
Background: Patients with acute lymphoblastic leukemia (ALL) are at risk for hyperglycemia due to asparaginase, glucocorticoids, and possible underlying predisposition for glucose intolerance. The use of metformin in pediatric oncology patients is not yet widespread; however, it may be used to control blood glucose levels. Observation: We report a young adult with T-cell ALL in maintenance chemotherapy who developed hemolysis 2 weeks after starting metformin, with resolution upon cessation of metformin. Conclusions: We present this case to increase awareness of metformin-related hemolysis, review the literature, and discuss possible mechanisms for this adverse event.
Authors
- Michael Jeng (ORCID: https://orcid.org/0000-0001-8200-8484)
- Louise Lo
- Karen Chao (ORCID: https://orcid.org/0000-0003-4163-3165)
- Wendy B. Wong (ORCID: https://orcid.org/0009-0009-3325-3593)
- Bradley Callas
- Priya S. Srivastava (ORCID: https://orcid.org/0009-0006-9607-5040)
Institutions
- Creighton University (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1097/mph.0000000000003317
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00